Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Farmers Insurance
Express Scripts
Argus Health
Queensland Health
Fish and Richardson
QuintilesIMS
Chinese Patent Office
Covington

Generated: July 19, 2018

DrugPatentWatch Database Preview

Mesna - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for mesna and what is the scope of mesna patent protection?

Mesna
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Mylan Institutional, Mylan Labs Ltd, Sagent Pharms, Teva Pharms Usa, West-ward Pharms Int, and Baxter Hlthcare, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for mesna. Seven suppliers are listed for this compound.
Summary for mesna
US Patents:0
Tradenames:2
Applicants:8
NDAs:9
Drug Master File Entries: 10
Suppliers / Packagers: 7
Bulk Api Vendors: 83
Patent Applications: 55
DailyMed Link:mesna at DailyMed
Pharmacology for mesna
Medical Subject Heading (MeSH) Categories for mesna
Synonyms for mesna
19767-45-4
2-Mercapto-ethan-sulfonsaeure, natrium-salz
2-mercaptoethane sulfonate
2-Mercaptoethane sulfonate sodium
2-MERCAPTOETHANE SULFONIC ACID
2-mercaptoethane sulfonic acid sodium salt
2-Mercaptoethanesulfonate, sodium
2-Mercaptoethanesulfonic acid monosodium salt
2-mercaptoethanesulfonic acid sodium
2-Mercaptoethanesulfonic acid sodium salt
2-Mercaptoethanesulfonic,Mesna
2-mercaptoethanesulphonic acid sodium salt
2-UI>>uOO>>CEa AAENI
3375-50-6 (parent cpd)
A M AAENI
A8469
AB0013231
AB01274734-01
AB2000259
AC-6011
AC1Q1VK3
AC1Q1VK4
ACMC-209f1l
AK163673
AKOS006220661
AKOS015960755
ANW-23767
AS-13260
ASTA-D 7093
BB_SC-5473
BC204054
C2H5NaO3S2
CAS-19767-45-4
CCG-40134
CCRIS 3712
CHEBI:31824
CHEMBL975
coenzyme M
Coenzyme M sodium salt
CPD000059219
CS-1364
CTK4E2249
D 7093
D-7093
D01459
D0C3YQ
DSSTox_CID_809
DSSTox_GSID_20809
DSSTox_RID_75800
DTXSID1020809
EBD6310
EINECS 243-285-9
EN300-49858
Ethanesulfonic acid, 2-mercapto-, monosodium salt
H751
HMS1921D10
HMS2092N09
HMS2236L05
HMS3259D13
HMS3372M11
HMS3655M06
HMS502F17
HS-CoM Na
HY-13679
I09-0289
KB-274297
KBio3_002565
KBioGR_000501
KS-00000V6Q
KSC542E4T
LS-7484
M-2956
M0913
mercaptoethanesulfonic acid sodium salt
Mesna (JAN/USAN/INN)
Mesna (Uromitexan, Mesnex)
Mesna [USAN:BAN:INN]
Mesna [USAN:USP:INN:BAN]
Mesna, coenzyme M
Mesna, Shionogi
Mesnex
Mesnex (TN)
Mesnum
Mesnum [INN-Latin]
Mexan
MFCD00007535
Mistabron
Mistabronco
Mitexan
MLS001074691
MLS001333251
MLS001333252
MolPort-003-666-395
Mucofluid
Natrium 2-mercaptoethansulfonat
NC00648
NCGC00094939-01
NCGC00094939-02
NCGC00178318-04
NCGC00181166-01
NCGC00258417-01
NR7O1405Q9
NSC 113891
OR021914
potassium 2-sulfanylethanesulfonate
Prestwick_1005
Q-201713
RTR-036066
s1735
SAM002548937
SC-18811
SCHEMBL7993
SMR000059219
Sodium 2-mercaptoethane sulfonate
sodium 2-mercaptoethane-1-sulfonate
Sodium 2-mercaptoethanesulfonate
Sodium 2-mercaptoethanesulfonate; Mesnaum; Mesnex
Sodium 2-Mercaptoethanesulphonate
sodium 2-sulfanylethane-1-sulfonate
sodium, 2-mercapto-ethanesulfonate
sodium;2-sulfanylethanesulfonate
SPBio_000764
SPECTRUM1502014
Spectrum2_000752
Spectrum3_001483
Spectrum4_000041
Spectrum5_001174
ST24049216
Tox21_112767
Tox21_112767_1
Tox21_200863
TR-036066
UCB-3983
UNII-NR7O1405Q9
Uromitexan
Uromitexan (TN)
Uromitexan;Mesnex
W-60283
XOGTZOOQQBDUSI-UHFFFAOYSA-M
Z1741968275

US Patents and Regulatory Information for mesna

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd MESNA mesna INJECTABLE;INTRAVENOUS 203364-001 Jul 18, 2014 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gland Pharma Ltd MESNA mesna INJECTABLE;INTRAVENOUS 206992-001 Dec 18, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare MESNEX mesna INJECTABLE;INTRAVENOUS 019884-001 Dec 30, 1988 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for mesna

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare MESNEX mesna INJECTABLE;INTRAVENOUS 019884-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare MESNEX mesna INJECTABLE;INTRAVENOUS 019884-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Teva
Cantor Fitzgerald
US Army
Covington
McKesson
Cerilliant
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.